We found for
Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?
